ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO)

Historical Holders from Q3 2020 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
ALXO on Nasdaq
Shares outstanding
53,136,600
Price per share
$1.08
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
27,785,299
Total reported value
$51,273,440
% of total 13F portfolios
0%
Share change
-1,287,450
Value change
+$2,394,855
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
60
Price from insider filings
$1.11
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Redmile Group, LLC 8.5% $4,780,699 4,641,455 Redmile Group, LLC 30 Jun 2025
HBM Healthcare Investments (Cayman) Ltd. 8.4% +27% $2,205,000 +$525,805 4,500,000 +31% HBM Healthcare Investments (Cayman) Ltd. 31 Mar 2025
TANG CAPITAL PARTNERS LP 6.3% $1,615,473 3,296,883 TANG CAPITAL MANAGEMENT, LLC 31 Dec 2024
MILLENNIUM MANAGEMENT LLC 6% +18% $5,706,871 +$861,071 3,188,196 +18% Millennium Management LLC 17 Oct 2025
FMR LLC 3.4% $881,449 1,798,875 FMR LLC 29 Nov 2024
As of 30 Sep 2025, ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) has 60 institutional shareholders filing 13F forms. They hold 27,785,299 shares. of 53,136,600 outstanding shares (52%) .

Top 25 institutional shareholders own 51% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
venBio Partners LLC 18% 9,699,925 0% 10% $17,750,863
Redmile Group, LLC 6.3% 3,332,983 -1.7% 0.59% $6,099,359
MILLENNIUM MANAGEMENT LLC 4.9% 2,622,861 +432% 0% $4,799,836
Almitas Capital LLC 4.8% 2,536,891 -0.06% 1.1% $4,642,511
VANGUARD GROUP INC 2.9% 1,528,619 -4.5% 0% $2,797,372
ACADIAN ASSET MANAGEMENT LLC 2.3% 1,220,825 -3.7% 0% $2,233,000
Driehaus Capital Management LLC 1.5% 795,777 0.01% $1,456,272
TWO SIGMA ADVISERS, LP 1.4% 719,800 +2.3% 0% $1,317,234
AMERIPRISE FINANCIAL INC 1.2% 652,897 0% $1,194,802
TWO SIGMA INVESTMENTS, LP 1.1% 606,671 +27% 0% $1,110,208
BANK OF AMERICA CORP /DE/ 1% 530,828 -49% 0% $971,415
Privium Fund Management B.V. 0.96% 509,059 0% 0.17% $931,578
BANK OF MONTREAL /CAN/ 0.89% 474,781 -29% 0% $868,849
BlackRock, Inc. 0.84% 447,692 -37% 0% $819,277
GEODE CAPITAL MANAGEMENT, LLC 0.66% 352,335 +12% 0% $645,030
JANE STREET GROUP, LLC 0.34% 180,416 -11% 0% $330,161
UBS Group AG 0.32% 172,570 -40% 0% $315,803
RENAISSANCE TECHNOLOGIES LLC 0.31% 164,499 +93% 0% $301,033
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.21% 113,063 -31% 0% $206,905
STATE STREET CORP 0.21% 111,928 -9.9% 0% $204,828
BANK OF NOVA SCOTIA 0.2% 105,858 0% 0% $193,720
NORTHERN TRUST CORP 0.18% 95,160 -30% 0% $174,143
IEQ CAPITAL, LLC 0.17% 92,233 0% $168,786
GSA CAPITAL PARTNERS LLP 0.17% 88,165 +8.4% 0.01% $161,000
MORGAN STANLEY 0.16% 85,290 -27% 0% $156,081

Institutional Holders of ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 37,992 $41,031 -$87 108% 1
2025 Q3 27,785,299 $51,273,440 +$2,394,855 183% 60
2025 Q2 29,072,911 $12,569,366 -$2,788,794 41.51% 60
2025 Q1 34,764,459 $21,657,477 -$4,297,866 62.3% 83
2024 Q4 41,028,903 $68,515,849 -$8,509,646 167% 85
2024 Q3 45,458,855 $83,126,318 -$40,254,396 182% 92
2024 Q2 48,512,647 $292,408,667 -$2,808,992 603% 109
2024 Q1 45,775,215 $510,406,593 -$4,932,180 1,115% 104
2023 Q4 35,654 $530,888 +$530,888 1,489% 2
2023 Q3 33,283,050 $159,762,114 -$6,351,370 480% 76
2023 Q2 34,283,564 $257,463,245 -$6,376,896 751% 74
2023 Q1 35,697,467 $161,353,347 -$6,004,486 452% 85
2022 Q4 36,433,730 $410,607,763 -$2,053,176 1,127% 86
2022 Q3 36,027,559 $344,783,761 +$5,891,483 957% 93
2022 Q2 35,473,772 $286,977,201 -$17,010,912 808.99% 90
2022 Q1 36,780,532 $621,647,079 +$3,005,970 1,690% 93
2021 Q4 36,267,690 $779,408,495 -$56,103,707 2,149% 101
2021 Q3 34,488,155 $2,547,285,171 +$109,290,995 7,385.98% 111
2021 Q2 33,299,638 $1,820,804,682 -$28,036,884 5,467.99% 101
2021 Q1 32,235,034 $2,373,321,361 +$119,541,087 7,373.97% 90
2020 Q4 30,524,457 $2,626,526,882 +$420,173,605 8,619.96% 85
2020 Q3 27,250,196 $1,027,708,220 +$1,027,708,283 3,774.01% 56